Development of a target identification approach using native mass spectrometry

• Published in: Scientific reports 2021-01, Vol.11 (1), p.2387-12, Article 2387
• Main Authors: Liu, Miaomiao, Van Voorhis, Wesley C., Quinn, Ronald J.
• Format: Article
• Language: English
• Subjects: 631/154; 631/154/555; 639/638/11/296; Drug development; Humanities and Social Sciences; Ligands; Mass spectrometry; Mass spectroscopy; multidisciplinary; Protein interaction; Proteins; Science; Science (multidisciplinary); Scientific imaging; Therapeutic targets; Thioredoxin
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-021-81859-4

A key step in the development of new pharmaceutical drugs is the identification of the molecular target and distinguishing this from all other gene products that respond indirectly to the drug. Target identification remains a crucial process and a current bottleneck for advancing hits through the discovery pipeline. Here we report a method, that takes advantage of the specific detection of protein–ligand complexes by native mass spectrometry (MS) to probe the protein partner of a ligand in an untargeted method. The key advantage is that it uses unmodified small molecules for binding and, thereby, it does not require labelled ligands and is not limited by the chemistry required to tag the molecule. We demonstrate the use of native MS to identify known ligand–protein interactions in a protein mixture under various experimental conditions. A protein–ligand complex was successfully detected between parthenolide and thioredoxin ( Pf Trx) in a five-protein mixture, as well as when parthenolide was mixed in a bacterial cell lysate spiked with Pf Trx. We provide preliminary data that native MS could be used to identify binding targets for any small molecule.